The candidate gene approach has already paid some dividends in trying to un
derstand the complex genetics of polycystic ovary syndrome (PCOS). In terms
of steroidogenic abnormalities, CYP11a-encoding P450 side chain cleavage-a
ppears to be a major susceptibility locus. In relation to the well-describe
d metabolic disturbances in PCOS, the insulin gene variable number tandem r
epeat (VNTR) appears to be a promising candidate, at least in populations s
tudied in the UK. Finally, genes implicated in ovarian follicular developme
nt may have a role in the aetiology of PCOS, as demonstrated by recent iden
tification of the follistatin gene as a potential disease locus. It seems u
nlikely that PCOS can be explained on the basis of a single gene disorder a
lthough, in a given family, one gene may have a predominant effect. An olig
ogenic model seems the most appropriate basis on which to understand the ge
netic origins of this very common disorder. The candidate gene approach has
been useful to date, but it may prove important in the near future to perf
orm an anonymous genome-wide scan to identify hitherto unheralded susceptib
ility loci.